Status:

COMPLETED

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

Lead Sponsor:

Gilead Sciences

Conditions:

Hepatitis C Virus Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The primary objective of this study is to evaluate the efficacy, safety and tolerability of treatment with sofosbuvir/velpatasvir (Epclusa®; SOF/VEL) with ribavirin (RBV) for 24 weeks in adults with c...

Eligibility Criteria

Inclusion

  • Key
  • Willing and able to provide written informed consent
  • HCV genotype determined by the Central Laboratory
  • HCV RNA \> LLOQ at screening
  • Participated and completed a Gilead sponsored HCV treatment study of direct acting antiviral (DAA) containing regimens.
  • Male and female of childbearing potential must agree to use protocol specified method(s) of contraception
  • Key

Exclusion

  • Current or prior history: Clinically-significant illness (other than HCV) or any other major medical disorder that may interfere with treatment, assessment or compliance with the protocol; individuals currently under evaluation for a potentially clinically-significant illness (other than HCV) are also excluded.
  • Screening ECG with clinically significant abnormalities
  • Laboratory results outside of acceptable ranges at screening
  • Infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV)
  • NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.

Key Trial Info

Start Date :

December 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 15 2016

Estimated Enrollment :

69 Patients enrolled

Trial Details

Trial ID

NCT02300103

Start Date

December 1 2014

End Date

September 15 2016

Last Update

November 16 2018

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

San Diego, California, United States

2

San Marcos, California, United States

3

Aurora, Colorado, United States

4

Gainesville, Florida, United States